Clinical Trial Update: Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients

View source ↗

Summary

An update on an actively recruiting clinical trial (NCT05973344) studying anti-cancer immune checkpoint inhibitors to understand and anticipate therapeutic and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University Hospital, Brest | Conditions: Cancer | Status: RECRUITING